Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
20 mai 2024 07h00 HE
|
Ocugen
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Cell and Gene Therapy Business Outlook 2024: News Briefs and Analysis of the Science That will Shape Tomorrow's Business and Tracked Deals Between CAGT Companies
20 mai 2024 05h04 HE
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering. With thousands of potential therapies on the...
Cell and Gene Therapy Manufacturing Research Report 2024
15 mai 2024 09h07 HE
|
Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
15 mai 2024 06h30 HE
|
Ocugen
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Ocugen Provides Business Update with First Quarter 2024 Financial Results
14 mai 2024 08h00 HE
|
Ocugen
All three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progressOCU400 on track to meet 2026 Biologics License Application (BLA) and Market...
Global Cell Therapy and Gene Therapy Market Report 2023-2029
13 mai 2024 11h34 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029" report has been added to ResearchAndMarkets.com's offering.A newly released...
Global Xerostomia Therapeutics Analysis & Forecast to 2024-2034: $3.69 Billion Market Expanding Amid Growing Cases of Parkinson's, Hypertension, and Diabetes
13 mai 2024 05h51 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global Xerostomia Therapeutics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Ocugen to Present at May 2024 Investor Conferences
10 mai 2024 07h45 HE
|
Ocugen
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
09 mai 2024 16h05 HE
|
Adverum Biotechnologies, Inc.
- Phase 2 LUNA interim analysis to be presented at ASRS Annual Scientific Meeting on July 17th, 2024 in Stockholm, Sweden - $193.3 million in cash, cash equivalents and short-term investments...
Global Cell and Gene Therapy in Ophthalmology Research Report 2024: Market Anticipated to Soar with Projected CAGR Growth of 50.8% by 2029
09 mai 2024 09h43 HE
|
Research and Markets
Dublin, May 09, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies in Ophthalmology" report has been added to ResearchAndMarkets.com's offering.Despite the high cost of therapies, linked to the...